🔎 Trials Near Me

Почетна › Рак јајника › Њујорк

Kliničke studije za Рак јајника u državi Њујорк

101 studija za Рак јајника traži učesnike na lokacijama u državi Њујорк.

Gradovi u državi Њујорк

Zvanični tekst studije (na engleskom)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, East White Plains
  • NYU Langone Hospital - Long Island, Mineola
  • и још 3
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07001748

A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

  • START New York Long Island LLC, Lake Success
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07778498

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • University of Rochester Medical Center, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT06915025

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New York Long Island LLC, Lake Success
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • и још 8
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • NYU Langone Hospital - Long Island ( Site 0015), Mineola
  • Laura and Isaac Perlmutter Cancer Center ( Site 0076), New York
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06824467

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • Womens Cancer Care Associates, LLC ( Site 0023), Albany
  • Memorial Sloan Kettering Cancer Center ( Site 0072), New York
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT07318558

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Albany Medical Center, Albany
  • NYU Langone Hospital - Brooklyn, Brooklyn
  • Memorial Sloan Kettering Commack, Commack
  • и још 12
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  • Site 0173, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Жене · Ажурирано 9. 11. 2026. · NCT04516447

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Albany Medical Center, Albany
  • Women's Cancer Care Associates LLC, Albany
  • Northwell Health Imbert Cancer Center, Bay Shore
  • и још 29
Тражи се учесник
Узраст од 35 до 50 · Жене · Ажурирано 6. 11. 2026. · NCT04251052

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • The Woman's Health Pavilion, Howard Beach
  • The Woman's Health Pavilion, Westbury
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Жене · Ажурирано 5. 11. 2026. · NCT05051722

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • Northwell Health Cancer Institute, Lake Success
  • Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06695845

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • Mount Sinai, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06303505

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0126 - Wilmot Cancer Center, Rochester
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 30. 10. 2026. · NCT05128825

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA04-0, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mount Sinai Tisch Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 28. 10. 2026. · NCT06819007

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York
Тражи се учесникФаза 1/2
Узраст од 18 до 90 · Оба пола · Ажурирано 28. 10. 2026. · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
  • Clinical Research Alliance, Inc, Westbury
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06330064

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Northwell Health, LLC PRIME, Lake Success
  • NYU Langone Health, New York
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06161025

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • NYU Langone Medical Center, New York
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT04981119

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

  • Roswell Park Comprehensive Cancer Center, Buffalo
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07489287

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Hematology Oncology Associates of Central New York, East Syracuse
  • Northwell Health Cancer Institute, Lake Success
  • Memorial Sloan-Kettering Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Imbert Cancer Center /ID# 275634, Bay Shore
  • Northwell Health Cancer Institute At Huntington /ID# 276814, Greenlawn
  • Northwell Health Center for Advanced Medicine. /ID# 275641, Lake Success
  • и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 20. 10. 2026. · NCT06890338

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • New York Cancer & Blood Specialists, New York
  • University of Rochester - Wilmot Cancer Institute, Rochester
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

  • Research Site, Albany
  • Research Site, Buffalo
  • Research Site, New York
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 16. 10. 2026. · NCT07816666

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06623396

EHR Intervention to Increase HBOC Genetic Testing

  • Columbia University Irving Medical Center, New York
Тражи се учесник
Узраст од 21 до 75 · Жене · Ажурирано 15. 10. 2026. · NCT07876349

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  • Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07186842

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

  • Mount Sinai Health System, New York
  • Memorial Sloan Kettering Cancer Center, New York
Тражи се учесник
Узраст 18 и старији · Жене · Ажурирано 15. 10. 2026. · NCT05287451

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Columbia University Medical Center /ID# 277990, New York
  • SUNY Upstate Medical University - Syracuse /ID# 277245, Syracuse
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 13. 10. 2026. · NCT07059845

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • NYU Longone Health (Long Island), Long Island City
  • NYU Longone Health (Manhattan), Manhattan
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06799065

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07749586

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Start (Nyli), Lake Success
  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06293898

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.